Literature DB >> 28503430

Long-term rotational stability and visual outcomes of a single-piece hydrophilic acrylic toric IOL: a 1.5-year follow-up.

Balázs Gyöngyössy1, Paul Jirak2, Ulrich Schönherr1.   

Abstract

AIM: To evaluate the rotational stability and visual outcomes of a single-piece hydrophilic acrylic toric intraocular lenses (IOL) over a 1.5-year follow-up period. Data from the 6-month follow-up study have been previously reported.
METHODS: Forty eyes of 26 cataract patients (mean age: 72.8±7.9y) with pre-existing corneal astigmatism of 1.0 to 2.6 D were enrolled in the study. Mean axial length was 23.17±0.88 mm. Main outcome measures after implantation of the Torica-aA IOL (HumanOptics) were IOL rotational stability, subjective refraction, astigmatism correction, uncorrected and corrected distance visual acuity (UDVA, CDVA).
RESULTS: There was no significant change in the parameters evaluated between the 6-month and 1.5-year follow-ups. At last visit, mean absolute IOL rotation (objective method) was 1.81°±1.87° (range 0.00° to 7.20°) with 78.6% of eyes having IOL rotation <3°, 92.9% of eyes <5° and 100% of eyes <8°. No patient required secondary IOL repositioning during the course of the study. Mean residual refractive cylinder was -0.60±0.40 D. There was a significant reduction in the magnitude of the J0 vector postoperatively (P<0.0001) with a mean absolute change of 0.76±0.40 D. The mean J45 vector was close to zero preoperatively and postoperatively and didn't change significantly (P=0.28). Mean monocular UDVA and CDVA was 0.09±0.12 logMAR and -0.01±0.12 logMAR, respectively. No treatment with Nd:YAG laser was required.
CONCLUSION: The Torica-aA IOL shows good and stable visual performance and rotational stability over a 1.5-year follow-up period.

Entities:  

Keywords:  astigmatism; cataract; hydrophilic acrylic; intraocular lenses; rotational stability

Year:  2017        PMID: 28503430      PMCID: PMC5406635          DOI: 10.18240/ijo.2017.04.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

1.  Vector analysis of corneal and refractive astigmatism changes following toric pseudophakic and toric phakic IOL implantation.

Authors:  Nienke Visser; Tos T J M Berendschot; Noël J C Bauer; Rudy M M A Nuijts
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-06       Impact factor: 4.799

2.  Factors influencing 1-year rotational stability of AcrySof Toric intraocular lenses.

Authors:  Xiangjia Zhu; Wenwen He; Keke Zhang; Yi Lu
Journal:  Br J Ophthalmol       Date:  2015-06-18       Impact factor: 4.638

3.  Clinical Outcomes After Cataract Surgery With a New Transitional Toric Intraocular Lens.

Authors:  Tiago B Ferreira; Tos T J M Berendschot; Filomena J Ribeiro
Journal:  J Refract Surg       Date:  2016-07-01       Impact factor: 3.573

4.  Rotational stability and visual outcome after implantation of a new toric intraocular lens for the correction of corneal astigmatism during cataract surgery.

Authors:  Alexander Bachernegg; Theresa Rückl; Wolfgang Riha; Günther Grabner; Alois K Dexl
Journal:  J Cataract Refract Surg       Date:  2013-07-02       Impact factor: 3.351

5.  Comparison of the visual outcomes and OPD-scan results of AMO Tecnis toric and Alcon Acrysof IQ toric intraocular lenses.

Authors:  Tiago B Ferreira; Ana Almeida
Journal:  J Refract Surg       Date:  2012-07-13       Impact factor: 3.573

6.  Rotational stability and posterior capsule opacification of a plate-haptic and an open-loop-haptic intraocular lens.

Authors:  Ana Prinz; Thomas Neumayer; Wolf Buehl; Lorenz Vock; Rupert Menapace; Oliver Findl; Michael Georgopoulos
Journal:  J Cataract Refract Surg       Date:  2011-02       Impact factor: 3.351

Review 7.  Toric Intraocular Lenses in the Correction of Astigmatism During Cataract Surgery: A Systematic Review and Meta-analysis.

Authors:  Line Kessel; Jens Andresen; Britta Tendal; Ditte Erngaard; Per Flesner; Jesper Hjortdal
Journal:  Ophthalmology       Date:  2015-11-18       Impact factor: 12.079

8.  Rotational stability and patient satisfaction after implantation of a new toric IOL.

Authors:  Balazs Gyöngyössy; Paul Jirak; Ulrich Schönherr
Journal:  Eur J Ophthalmol       Date:  2015-11-05       Impact factor: 2.597

9.  Astigmatism management in cataract surgery with Precizon(®) toric intraocular lens: a prospective study.

Authors:  Carolina Vale; Carlos Menezes; J Firmino-Machado; Pedro Rodrigues; Miguel Lume; Paula Tenedório; Pedro Menéres; Maria do Céu Brochado
Journal:  Clin Ophthalmol       Date:  2016-01-19

Review 10.  [Toric intraocular lenses and correction of astigmatism].

Authors:  Arne Viestenz; S Walter; Anja Viestenz; W Behrens-Baumann; A Langenbucher
Journal:  Ophthalmologe       Date:  2007-07       Impact factor: 1.174

View more
  5 in total

1.  Toric IOL repositioning.

Authors:  Ankur Gupta; Alexander Ionides
Journal:  Int Ophthalmol       Date:  2022-07-11       Impact factor: 2.029

2.  Long-term outcomes of cataract surgery with toric intraocular lens implantation by the type of preoperative astigmatism.

Authors:  Tetsuro Oshika; Shinichiro Nakano; Yoshifumi Fujita; Yuya Nomura; Yasushi Inoue; Hiroyasu Takehara; Kazunori Miyata; Masato Honbou; Toru Sugita; Tsutomu Kaneko
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Rotational stability of a new multicomponent intraocular lens.

Authors:  Harvey S Uy; Carolina Tesone-Coelho
Journal:  Clin Ophthalmol       Date:  2019-09-26

4.  Early Postoperative Rotational stability and its related factors of a single-piece acrylic toric intraocular lens.

Authors:  Shuyi Li; Xi Li; Suhong He; Qianyin Zheng; Xiang Chen; Xingdi Wu; Wen Xu
Journal:  Eye (Lond)       Date:  2019-07-12       Impact factor: 3.775

Review 5.  Toric intraocular lenses: Expanding indications and preoperative and surgical considerations to improve outcomes.

Authors:  Vivek Mahendrapratap Singh; Muralidhar Ramappa; Somasheila I Murthy; Audrey Talley Rostov
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.